There are several stocks that passed through the screen and (BNTC) is one of them. Here are the key reasons why this stock is a solid choice for "trend" investing. A solid price increase over a ...

This has helped BNTC to earn a Zacks Rank #2 (Buy), further underscoring the company’s solid position. You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here .

Benitec Biopharma Limited (BNTC) closed the last trading session at $11.19, gaining 4.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ...

Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $11.29 and traded as high as $ ...

We can readily understand why investors are attracted to unprofitable companies. For example, Benitec Biopharma (NASDAQ:BNTC) shareholders have done very well over the last year, with the share price ...

On Friday, H.C. Wainwright analysts maintained their Buy rating and $28.00 price target for Benitec BioPharma (NASDAQ:BNTC) ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Benitec Biopharma (BNTC – Research Report), with a price target of $30.00. The company’s shares closed ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Benitec Biopharma (BNTC – Research Report) and Halozyme (HALO – Research Report) with bullish ...

Benitec Biopharma Inc. (Nasdaq: BNTC) today announced the pricing of its underwritten public offering of 15,544,041 shares of its common stock (or pre-funded warrants to purchase ...